66
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
876448
Effimune is a biotechnology company that conducts research and development of drugs for transplantation and immune-mediated diseases.
Didier Coquoz: Chief Development and Regulatory OfficerPast Role: CytunePharma, Chief Development and Business Development Officer
About the Company
Effimune is a biotechnology company that conducts research and development of drugs for transplantation and immune-mediated diseases.
Effimune targeting cells of the immune system to restore the balance between effector and regulatory mechanisms.
Effimune was founded in 2017 and was headquartered in Nantes, France.
